Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

InnovationRx: Hinge May Herald A New Wave Of Digital Health IPOs

Summary by Forbes
In this week’s edition of InnovationRx, we look at how Hinge Health’s successful IPO may be a trendsetter, Indian billionaire Kiran Mazumdar-Shaw’s ‘biosimilars’ business, RFK’s changes to Covid vaccine guidance and more.

2 Articles

ForbesForbes
Center

InnovationRx: Hinge May Herald A New Wave Of Digital Health IPOs

In this week’s edition of InnovationRx, we look at how Hinge Health’s successful IPO may be a trendsetter, Indian billionaire Kiran Mazumdar-Shaw’s ‘biosimilars’ business, RFK’s changes to Covid vaccine guidance and more.

·United States
Read Full Article
Barchart.comBarchart.com

Should You Buy Hinge Health After the HNGE Stock IPO?

Hinge Health stock recently went public via an IPO. Is the health-tech company a good buy right now given its steady revenue and earnings growth profile?

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Barchart.com broke the news in on Tuesday, May 27, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Robert F. Kennedy Jr. icon

Robert F. Kennedy Jr.

Stock Markets icon

Stock Markets

Health icon

Health

IPO icon

IPO

Coronavirus icon

Coronavirus

India icon

India

India Economy icon

India Economy

News
For You
SearchBlindspotLocal